Walgreens Boots Alliance, Inc. (WBA)
Pre-market:
| Previous close | 18.05 |
| Open | 17.81 |
| Bid | 17.80 x 3000 |
| Ask | 17.83 x 3000 |
| Day's range | 17.62 - 17.98 |
| 52-week range | 17.51 - 35.38 |
| Volume | |
| Avg. volume | 12,825,348 |
| Market cap | 15.365B |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.00 (5.61%) |
| Ex-dividend date | 16 Feb 2024 |
| 1y target est | N/A |
- Bloomberg
Walgreens Is Opening a New Pharmacy For Cell and Gene Therapies
(Bloomberg) -- Walgreens Boots Alliance Inc. is opening a new center dedicated to bringing emerging cell and gene therapies to patients with complex, chronic conditions like cancer, cystic fibrosis and Crohn’s disease.Most Read from BloombergBiden’s Gains Against Trump Vanish on Deep Economic Pessimism, Poll ShowsMalaysia in Talks With Tycoons on Casino to Revive $100 Billion Forest CityZuckerberg Asks for Patience as Meta’s AI Push Spooks InvestorsMeta’s Miss Sparks Fears in Tech With More Earn
- Insider Monkey
10 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 10 best healthcare stocks to buy under $20. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Best Healthcare Stocks to Buy Under $20. Global Healthcare Outlook for 2024 As 2024 progresses, the optimism surrounding the healthcare […]
- Zacks
Walgreens Boots Alliance, Inc. (WBA) Is a Trending Stock: Facts to Know Before Betting on It
Walgreens (WBA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
